This announcement details the completion of a capital increase and subsequent industrial and commercial registration change for Yong'an Kangjian Pharmaceutical (Wuhan) Co., Ltd., a wholly-owned subsidiary of Qianjiang Yong'an Pharmaceutical Co., Ltd. The parent company injected RMB 50 million, increasing the subsidiary's registered capital to RMB 160 million, while maintaining 100% ownership. This move supports the subsidiary's business development.
Summary generated by AI · Always verify with source document
Stock Code: 002365 Stock Abbreviation: Yong'an Pharmaceutical Announcement No.: 2026-13
Qianjiang Yong'an Pharmaceutical Co., Ltd. Announcement on Capital Increase and Industrial and Commercial Registration Change of Wholly-Owned Subsidiary Yong'an Kangjian
The Company and all members of the Board of Directors guarantee the truthfulness, accuracy, and completeness of the information disclosed herein, and there are no false records, misleading statements, or major omissions.
Sign in to read the full translation
Free accounts get 10 full releases per month. Pro subscribers get unlimited access.